Send Away Test for Oncotype DX Breast Recurrence Score
Provision of Oncotype DX Breast Recurrence Score via a genomic assay that provides a personalised insight into an individual patient's breast cancer biology.
Buyer
Gloucestershire Hospitals NHS Foundation Trust
Value
£229,500
Published
8 Oct 2026
Closes
Not provided
Procurement details
Source
Find a Tender
Region
Gloucestershire
Procurement method
Limited
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
85111800
Pathology services
Lots
Lot 1 Send Away Test for Oncotype DX Breast Recurrence Score
£229,500
Oncotype DX Breast Recurrence Score is a genomic assay that provides a personalised insight into an individual patient’s breast cancer biology. The Oncotype DX Breast Recurrence Score test addresses the issue overtreatment with chemotherapy, particularly for patients with lymph node-positive breast cancer. In providing a more precise information about tumour...
Delivery: Gloucestershire
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.